医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo): An open-label, 2×2 factorial randomised phase 3 trial

广告
第一作者: Earl,H.M.
作者单位: Nottingham City Hospital, Hucknall Road, Nottingham, United Kingdom [1] Beatson West of Scotland Cancer Centre, 1053 Great Western Road, Glasgow, United Kingdom [2] National Institute for Health Research, Cambridge Biomedical Research Centre and Cambridge [3] Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, University of Birmingham [4] Department of Surgery, Royal Bournemouth Hospital, Castle Lane East, Bournemouth, United Kingdom [5] Royal Surrey County Hospital NHS Foundation Trust, Egerton Road, Guildford, United Kingdom [6] Royal Bournemouth Hospital, Castle Lane East, Bournemouth, United Kingdom [7] University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Hills Road, Cambridge [8] Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road [9] Dorset Cancer Centre, Poole Hospital NHS Trust, Poole, United Kingdom [10] CancerResearch UK Cambridge Institute, Cambridge, United Kingdom [11] Department of Medical Oncology, St Bartholomew's Hospital, West Smithfield, London, United Kingdom [12] Breast Oncology Unit, Guys Hospital, Thomas Guy House, St Thomas Street, London, United Kingdom [13] Department of Oncology, Cambridge Cancer Trials Centre, Addenbrooke's Hospital, Cambridge, United [14] University of Melbourne, Shepparton, VIC, Australia [15] Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Road, Coventry, United Kingdom [16]
发布时间 2014-04-05
提交
  • 浏览2
The lancet oncology

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new智医 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷